Divergent projections of the prelimbic cortex mediate autism- and anxiety-like behaviors.

The comorbidity of autism spectrum disorder and anxiety is common, but the underlying circuitry is poorly understood. Here, Tmem74-/- mice showed autism- and anxiety-like behaviors along with increased excitability of pyramidal neurons (PNs) in the prelimbic cortex (PL), which were reversed by Tmem74 re-expression and chemogenetic inhibition in PNs of the PL. To determine the underlying circuitry, we performed conditional deletion of Tmem74 in the PNs of PL of mice, and we found that alterations in the PL projections to fast-spiking interneurons (FSIs) in the dorsal striatum (dSTR) (PLPNs-dSTRFSIs) mediated the hyperexcitability of FSIs and autism-like behaviors and that alterations in the PL projections to the PNs of the basolateral amygdaloid nucleus (BLA) (PLPNs-BLAPNs) mediated the hyperexcitability of PNs and anxiety-like behaviors. However, the two populations of PNs in the PL had different spatial locations, optogenetic manipulations revealed that alterations in the activity in the PL-dSTR or PL-BLA circuits led to autism- or anxiety-like behaviors, respectively. Collectively, these findings highlight that the hyperactivity of the two populations of PNs in the PL mediates autism and anxiety comorbidity through the PL-dSTR and PL-BLA circuits, which may lead to the development of new therapeutics for the autism and anxiety comorbidity.

Preparation and in vitro evaluation of glycyrrhetinic acid-modified curcumin-loaded nanostructured lipid carriers.

Curcumin, a phenolic antioxidant compound derived from the rhizome of the turmeric plant Curcuma longa, has proven to be a modulator of intracellular signaling pathways that control cancer cell growth, inflammation, invasion and apoptosis, revealing its anticancer potential. In this study, a Glycyrrhetinic Acid-Modified Curcumin-Loaded Nanostructured Lipid Carrier (Cur-GA-PEG-NLC) was prepared by the film ultrasound method to improve the tumor-targeting ability. The drug content was detected by an UV spectrophotometry method. The encapsulation efficiency of curcumin in the nanostructured lipid carriers (NLCs) was determined using a mini-column centrifugation method. The encapsulation efficiency for various Cur-GA-PEG-NLC was within the range of 90.06%-95.31% and particle size was between 123.1 nm and 132.7 nm. An in vitro MTT assay showed that Cur-GA10%-PEG-NLC had significantly high cellular uptake and cytotoxicity against HepG2 cells compared with other groups.

Preparation of electrodeposited Mo-Ni coating and its spectral properties.

Mo-Ni coatings were prepared on Ni alloy by electrodeposition method. The properties of microhardness, wear weight loss and friction coefficients, and thermal expansion of the coatings were investigated, respectively. Mo-Ni coatings were characterized with inductively coupled plasma-atomic emission spectroscopy (ICP-AES), energy-dispersive analyses of X-ray (EDAX), scanning electron microcopy (SEM), and X-ray diffraction (XRD) techniques, respectively. Mo-Ni coating shows higher microhardness, lower wear weight loss and friction coefficient compared with those of Ni alloy. The microhardness of Mo-Ni coating is as high as 518 HV, which is 72.67% higher than that of the Ni alloy (300 HV). The wear weight losses of Mo-Ni coating is 1.94 times lower than that of Ni alloy. The friction coefficient of Ni alloy and Mo-Ni coating are 0.640 and 0.559 respectively. The physical thermal expansion curve of Ni alloy has two the peaks in the ranges of 100-120 and 570-640 degrees C respectively; and that of Ni alloy+Mo-Ni coating has one the peaks in the ranges of 570-640 degrees C. The peak of the physical thermal expansion curve of Ni alloy+Mo-Ni coating in the ranges of 570-640 degrees C is much smaller than that of the Ni alloy. Because the part of nickel was replaced by molybdenum in the Ni lattice, molybdenum decreases the lattices transformation of nickel (bcc --> fcc). The reason for the formation of the small peak of the physical thermal expansion curve of Ni alloy+Mo-Ni coating in the ranges of 595-625 degrees C is the changes of MoNi4 and MoNi from the semi-crystalline structure to the crystalline structure respectively.

The influencing factors of clinical nurses' problem solving dilemma: a qualitative study.

PURPOSE: Problem solving has been defined as "a goal-directed sequence of cognitive and affective operations as well as behavioural responses to adapting to internal or external demands or challenges. Studies have shown that some nurses lack rational thinking and decision-making ability to identify patients' health problems and make clinical judgements, and have poor cognition and response to some clinical problems, easy to fall into problem-solving dilemma. This study aimed to understand the influencing factors of clinical nurses' problem solving dilemma, to provide a basis for developing training strategies and improving the ability of clinical nurses in problem solving. METHODS: A qualitative research was conducted using in-depth interviews from August 2020 to December 2020. A total of 14 participants from a tertiary hospital in Shanghai, China were recruited through purposive sampling combined with a maximum variation strategy. Data were analysed with the conventional content analysis method. RESULTS: Three themes and seven subthemes were extracted: nurse's own factors (differences in knowledge structure and thinking, differences in professional values, poor strain capacity); improper nursing management (low sense of organizational support, contradiction between large workload and insufficient manpower allocation); patient factors (the concept of emphasizing medicine and neglecting to nurse, individual differences of patients). CONCLUSION: The influencing factors of clinical nurses' problem-solving dilemma are diverse. Hospital managers and nursing educators should pay attention to the problem-solving of clinical nurses, carry out a series of training and counselling of nurses by using the method of situational simulation, optimize the nursing management mode, learn to use new media technology to improve the credibility of nurses to provide guarantee for effective problem-solving of clinical nurses.

Bis(2,2'-bipyridine)(2-hy-droxy-2,2-diphenyl-acetato)-copper(II) nitrate dihydrate.

In the title complex, [Cu(C(14)H(11)O(3))(C(10)H(8)N(2))(2)]NO(3)·2H(2)O, the Cu(II) atom is coordinated by four N atoms from two 2,2'-bipyridine ligands and two O atoms from one benzilate ligand in a distorted octa-hedral geometry. A supra-molecular network is formed via inter-molecular O-H⋯O and C-H⋯O hydrogen-bonding inter-actions. π-π stacking inter-actions between neighboring pyridine rings are also present, the centroid-centroid distance being 3.808 (2) Å.

Poly[(acetato-κO,O')aqua-(µ(4)-1H-benzimidazole-5,6-dicarboxyl-ato-κN:O,O:O,O:O)praseodymium(III)].

In the title complex, [Pr(C(9)H(4)N(2)O(4))(C(2)H(3)O(2))(H(2)O)](n), the Pr(III) ion is coordinated by five O atoms and one N atom from four benzimidazole-5,6-dicarboxyl-ate ligands, two O atoms from an acetate ligand and one water mol-ecule, giving a tricapped trigonal-prismatic geometry. The benzimidazole-5,6-dicarboxyl-ate and acetate ligands connect the Pr(III) ions, forming a layer in the ac plane; the layers are further linked by N-H⋯O and O-H⋯O hydrogen bonding and π-π stacking inter-actions between neighboring pyridine rings [the centroid-centroid distance is 3.467 (1) Å], assembling a three-dimensional supra-molecular network. The acetate methyl group is disordered over two positions with site-occupancy factors of 0.75 and 0.25.

miR-373 inhibits autophagy and further promotes apoptosis of cholangiocarcinoma cells by targeting ULK1.

Intrahepatic cholangiocarcinoma is a malignant tumor originating from intrahepatic bile ducts. Surgical therapy, radiotherapy, and chemotherapy are taken to treat this disease, but it is prone to recurrence and metastasis, with poor prognosis. Therefore, it is of great significance to explore new targets and molecular mechanisms for the development of cholangiocarcinoma cells. Clinical cholangiocarcinoma tissues from patients and four human cholangiocarcinoma cell lines were analyzed for microRNA-373 (miR-373) expression. For investigating whether miR-373 directly modulated unc-51 like autophagy activating kinase 1 (ULK1), dual-luciferase reporter assay was performed. In addition, CCK-8 assay, flow cytometry, western blot, and immunofluorescence were applied to evaluate the proliferation, apoptosis, and autophagy of cholangiocytic hepatocellular carcinoma cells. miR-373 downregulation was observed in clinical tissues and cell lines of cholangiocarcinoma. Overexpression of miR-373 reduced proliferation, enhanced apoptosis, and raised expression levels of pro-apoptosis proteins including BCL2 associated X (Bax), Caspase-3, and Caspase-9. Moreover, overexpression of miR-373 downregulated expression levels of microtubule-associated protein 1A/1B-light chain 3 (LC3)-II, Beclin-1, and promoted P62 expression on mRNA and protein levels. After miR-373 knockdown, all indexes of apoptosis and autophagy mentioned above were reversed. Luciferase activity was decreased after cotransfection of miR-373 mimic and wild-type ULK1 vector. Also, miR-373 overexpression inhibited ULK1 expression. Importantly, overexpression of miR-373 weakened expressions of ULK1, LC3, Beclin-1, and Bcl-2, and enhanced expressions of P62, Bax, Caspase-3, and Caspase-9. miR-373 mimic treatment and subsequent ULK1 overexpression, induced reverse regulation in expressions of these proteins, compared with overexpression of miR-373 only. miR-373 targeted ULK1 to initiate inhibition of autophagy and subsequent promotion of apoptosis in cholangiocarcinoma cells.

4-(4-Pyrid-yl)pyridinium 3',4,4'-tricarboxy-biphenyl-3-carboxyl-ate dihydrate.

In the title compound, C(10)H(9)N(2) (+)·C(16)H(9)O(8) (-)·2H(2)O, both the cation and anion possess crystallographically imposed centres of symmetry, causing the nitro-gen-bound H atom in the 4-(4-pyrid-yl)pyridinium cation and the acidic H atom of the carboxyl-ate groups at the 3 and 3' positions in the anion to be disordered over two positions with equal occupancies. In the crystal packing, the cations, anions and water mol-ecules are connected by O-H⋯O, C-H⋯O and N-H⋯N hydrogen bonds, forming layers parallel to (20). These layer are further connected into a three-dimensional supra-molecular network by O-H⋯O hydrogen bonds involving the water mol-ecules as H-atom donors and by weak π-π stacking inter-actions between neighbouring benzene and pyridine rings, with centroid-centroid distances of 3.756 (5) Å.

Poly[[aqua-(µ(2)-oxalato)(µ(2)-2-oxido-pyridinium-3-carboxylato)holmium(III)] monohydrate].

In the title complex, {[Ho(C(2)O(4))(C(6)H(4)NO(3))(H(2)O)]·(H(2)O)}(n), the Ho(III) ion is coordinated by three O atoms from two 2-oxidopyridinium-3-carboxylate ligands, four O atoms from two oxalate ligands and one water mol-ecule in a distorted bicapped trigonal-prismatic geometry. The 2-oxidopyridin-ium-3-carboxylate and oxalate ligands link the Ho(III) ions into a layer in (100). These layers are further connected by inter-molecular O-H⋯O hydrogen bonds involving the coordinated water mol-ecules to assemble a three-dimensional supra-molecular network. The uncoordin-ated water mol-ecule is involved in N-H⋯O and O-H⋯O hydrogen bonds within the layer.

Poly[(6-carboxy-picolinato-κO,N,O)(µ(3)-pyridine-2,6-dicarboxyl-ato-κO,N,O:O:O)dysprosium(III)].

In the title complex, [Dy(C(7)H(3)NO(4))(C(7)H(4)NO(4))](n), one of the ligands is fully deprotonated while the second has lost only one H atom. Each Dy(III) ion is coordinated by six O atoms and two N atoms from two pyridine-2,6-dicarboxyl-ate and two 6-carboxy-picolinate ligands, displaying a bicapped trigonal-prismatic geometry. The average Dy-O bond distance is 2.40 Å, some 0.1Å longer than the corresponding Ho-O distance in the isotypic holmium complex. Adjacent Dy(III) ions are linked by the pyridine-2,6-dicarboxyl-ate ligands, forming a layer in (100). These layers are further connected by π-π stacking inter-actions between neighboring pyridyl rings [centroid-centroid distance = 3.827 (3) Å] and C-H⋯O hydrogen-bonding inter-actions, assembling a three-dimensional supra-molecular network. Within each layer, there are other π-π stacking inter-actions between neighboring pyridyl rings [centroid-centroid distance = 3.501 (2) Å] and O-H⋯O and C-H⋯O hydrogen-bonding inter-actions, which further stabilize the structure.

Poly[bis-(4,4'-bipyridine)(µ(3)-4,4'-dicarboxybiphenyl-3,3'-di-carboxyl-ato)iron(II)].

In the polymeric title complex, [Fe(C(16)H(8)O(8))(C(10)H(8)N(2))(2)](n), the iron(II) cation is coordinated by four O atoms from three different 4,4'-dicarboxybiphenyl-3,3'-di-carboxyl-ate ligands and two N atoms from two 4,4'-bipyridine ligands in a distorted octa-hedral geometry. The 4,4'-dicarboxybiphenyl-3,3'-di-carboxyl-ate ligands bridge adjacent cations, forming chains parallel to the c axis. The chains are further connected by inter-molecular O-H⋯N hydrogen bonds, forming two-dimensional supra-molecular layers parallel to (010).

Hemi(4,4'-bipyridinium) hexa-fluorido-phosphate bis-(4-amino-benzoic acid) 4,4'-bipyridine monohydrate.

In the title compound, 0.5C(10)H(10)N(2) (2+)·PF(6) (-)·C(10)H(8)N(2)·2C(7)H(7)NO(2)·H(2)O, the cation is located on a center of symmetry. The crystal structure is determined by a complex three-dimensional network of inter-molecular O-H⋯O, O-H⋯N, N-H⋯N and N-H⋯F hydrogen bonds. π-π stacking inter-actions between neighboring pyridyl rings are also present; the centroid-centroid distance is 3.643 (5) Å. The hexa-fluoridophosphate anion is disordered over two positions with site-occupancy factors of ca 0.6 and 0.4.

Poly[diaqua-(µ(2)-oxalato-κO,O:O,O)(µ(2)-pyrazine-2-carboxyl-ato-κN,O:O,O')neodymium(III)].

In the title complex, [Nd(C(5)H(3)N(2)O(2))(C(2)O(4))(H(2)O)(2)](n), the Nd(III) atom is ten-coordinated by one N atom and three O atoms from two pyrazine-2-carboxyl-ate ligands, four O atoms from two oxalate ligands and two water mol-ecules in a distorted bicapped square-anti-prismatic geometry. The two crystallographically independent oxalate ligands, each lying on an inversion center, act as bridging ligands, linking Nd atoms into an extended zigzag chain. Neighboring chains are linked by the pyrazine-2-carboxyl-ate ligands into a two-dimensional layerlike network in the (10) plane. The layers are further connected by O-H⋯O and O-H⋯N hydrogen bonds, forming a three-dimensional supra-molecular network.

Poly[diaqua-µ-oxalato-µ-pyrazine-2-carbox-yl-ato-lanthanum(III)].

In the title complex, [La(C(5)H(3)N(2)O(2))(C(2)O(4))(H(2)O)(2)](n), the La(III) ion is coordinated by one N and three O atoms from two pyrazine-2-carboxylate ligands, by four O atoms from two oxalate ligands and by two O atoms of two water molecules, displaying a distorted bicapped square-anti-prismatic geometry. The carboxyl-ate groups of pyrazine-2-carboxyl-ate and oxalate ligands link the lanthanum metal centres, forming layers parallel to (10). The layers are further connected by inter-molecular O-H⋯O and N-H⋯O hydrogen-bonding inter-actions, forming a three-dimensional supra-molecular network.

4,4'-Bipyridinium bis(perchlorate)-4-aminobenzoic acid-4,4'-bipyridine-water (1/4/2/2).

In the structure of the title compound, C(10)H(10)N(2) (2+)·2ClO(4) (-)·4C(7)H(7)NO(2)·2C(10)H(8)N(2)·2H(2)O, the 4,4'-bipyridinium cation has a crystallographically imposed centre of symmetry. The cation is linked by N-H⋯N hydrogen bonds to adjacent 4,4'-bipyridine mol-ecules, which in turn inter-act via O-H⋯N hydrogen bonds with 4-amino-benzoic acid mol-ecules, forming chains running parallel to [30]. The chains are further connected into a three-dimensional network by N-H⋯O and O-H⋯O hydrogen-bonding inter-actions involving the perchlorate anion, the water mol-ecules and the 4-amino-benzoic acid mol-ecules. In addition, π-π stacking inter-actions with centroid-centroid distances ranging from 3.663 (6) to 3.695 (6) Šare present. The O atoms of the perchlorate anion are disordered over two sets of positions, with refined site occupancies of 0.724 (9) and 0.276 (9).

[Study on influence of buffer system on separate capacity of macroporous resin on ferulic liposome].

OBJECTIVE: To study the effect of buffer on separate capacity of macroporous resin. To evaluate the quality of ferulic acid liposome and determine its entrapment efficiency. METHOD: Different type of macroporous resin counterpoised by buffer system of Na2 HPO3-NaH2, PO3 was used to separate the free ferulic acid from the preparation and HPLC was used to determine the concentration of the ferulic acid to calculate the entrapment efficiency. RESULT: This method had good linearity in the range of 0.56 - 2.8 g x mL(-1) (r = 0.999 6). The precision RSD was less than 1.1%. The adsorption effect of macroporous resin on liposome was reduced while it had no effect on the absorption ability of macroporous resin on the ferulic acid by the usage of buffer. The recovery of HPD450 resin on blank liposome was between 97.2% - 100.8%, while the average recovery is 98.1%. CONCLUSION: Buffer system can enhance the separate ability of macroporous resin on liposome and free drug.

[Studies on ANN models of determination of tea polyphenol and amylose in tea by near-infrared spectroscopy].

The objectives of the present paper were to build the models for the determination of tea polyphenol (TP) and tea amylose (TA) in tea by near-infrared spectroscopy (NIR). According to the range of 7432.3-6155.7 cm(-1) and 5484.6-4192.5 cm(-1) of NIR spectra, the models are built for determining the contents of TP and TA in tea with the input layer, hidden layer and node ((8, 4, 1) and (7, 5, 1) respectively) in network structure by the artificial neural network. The correlation coefficient (r), the root mean square error of cross validation (RMSECV) and the root mean square error of prediction (RMSEP) were selected as the indexes for evaluating the performance of calibration models. The results show that r, RMSECV and RSECV by the model samples for TP and TA are 0.9847, 0.460 and 0.123, and 0.9470, 0.136 and 0.224 respectively, and r, RMSEP and RSEP by the prediction samples for TP and TA are 0.9804, 0.529 and 0.017, and 0.9682, 0.111 and 0.0298 respectively. These indicated that the NIRANN models can be used to determine the contents of TP and TA in tea.

Antidepressant-like effects of sarsasapogenin from Anemarrhena asphodeloides BUNGE (Liliaceae).

The aim of this study was to investigate the effects of sarsasapogenin from Anemarrhena asphodeloides BUNGE (Liliaceae) on the forced swimming test, and the central noradrenergic, dopaminergic and serotonergic activities in mice. Our results showed that sarsasapogenin treatment at 12.5, 25 and 50 mg/kg (p.o.) for 14 d significantly reduced the duration of immobility in the forced swimming test. These doses that affected the immobile response did not affect locomotor activity. In addition, the neurochemical assays showed that sarsasapogenin produced a marked increase of noradrenaline and serotonin levels at 50 mg/kg in both the hypothalamus and the hippocampus. Moreover, sarsasapogenin showed a monoamine oxidase inhibitory activity in the mouse brain. These findings suggest that the antidepressant activity of sarsasapogenin may involve the central monoaminergic neurotransmitter systems.